Systemic vasculitis

Targeting JAK/STAT pathway in Takayasu’s arteritis
Paul Régnier, Alexandre Le Joncour, Anna Maciejewski-Duval, Anne-Claire Desbois, Cloé Comarmond, Michelle Rosenzwajg, David Klatzmann, Patrice Cacoub, David Saadoun

Annals of the Rheumatic Diseases Mar 2020, annrheumdis-2019-216900; DOI: 10.1136/annrheumdis-2019-216900
Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis
Zachary Scott Wallace, Hyon Choi, John H Stone

Annals of the Rheumatic Diseases Apr 2020, 79 (4) e40; DOI: 10.1136/annrheumdis-2019-215009
IgA vasculitis in adults: few certainties and many uncertainties
Alojzija Hočevar, Matija Tomšič, Žiga Rotar

Annals of the Rheumatic Diseases Apr 2020, 79 (4) e47; DOI: 10.1136/annrheumdis-2018-214907
Response to ‘IgA vasculitis in adults: few certainties and many uncertainties’ by Hočevar et al
Alexander Tracy, Anuradhaa Subramanian, Nicola J Adderley, Lorraine Harper, Krishnarajah Nirantharakumar

Annals of the Rheumatic Diseases Apr 2020, 79 (4) e48; DOI: 10.1136/annrheumdis-2018-214951
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia
Kornelis S M van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Mar 2020, 79 (3) 393-399; DOI: 10.1136/annrheumdis-2019-216343
Rituximab for chronic periaortitis without evidence of IgG4-related disease: a long-term follow-up study of 20 patients
Maria Letizia Urban, Federica Maritati, Alessandra Palmisano, Paride Fenaroli, Francesco Peyronel, Giorgio Trivioli, Stefania Ferretti, Consuelo De Biase, Peter C Grayson, Francesco Pegoraro, Domenico Prisco, Paola Romagnani, Giacomo Emmi, Augusto Vaglio

Annals of the Rheumatic Diseases Mar 2020, 79 (3) 433-434; DOI: 10.1136/annrheumdis-2019-216258
Histopathological subgrouping versus renal risk score for the prediction of end-stage renal disease in ANCA-associated vasculitis
Onay Gercik, Emre Bilgin, Dilek Solmaz, Fulya Cakalagaoglu, Arzu Saglam, Ozge Aybi, Riza Can Kardas, Zeki Soypacaci, Gokhan Kabadayi, Tolga Yildirim, Idil Kurut Aysin, Omer Karadag, Servet Akar

Annals of the Rheumatic Diseases Feb 2020, annrheumdis-2019-216742; DOI: 10.1136/annrheumdis-2019-216742
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Dennis Scheicht

Annals of the Rheumatic Diseases Feb 2020, annrheumdis-2020-217041; DOI: 10.1136/annrheumdis-2020-217041
Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine
Pavel I Novikov, Nikolai M Bulanov, Anastasiia S Zykova, Sergey V Moiseev

Annals of the Rheumatic Diseases Feb 2020, 79 (2) e19; DOI: 10.1136/annrheumdis-2018-214508
Response to: ‘Prevention of infections in patients with antineutrophil cytoplasm antibody-associated vasculitis: potential role of hydroxychloroquine’ by Novikov et al
Andreas Kronbichler, David Jayne

Annals of the Rheumatic Diseases Feb 2020, 79 (2) e20; DOI: 10.1136/annrheumdis-2018-214735

Main menu

Systemic vasculitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Systemic vasculitis

Pages